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ABSTRACT
Headache disorders, characterized by recurrent headache, are among the most common disorders of the nervous system. Headache disorder is classified 
mainly into two major types, primary headache and secondary headache by the International Classification of Headache Disorders. Most types of 
headache are diagnosed by the clinical history and from headache classification committee of the International Headache Society (IHS). A number 
of intrinsic or extrinsic factors can trigger headache attack which release neurotransmitters and activate trigeminal vascular system. The grading of 
headache intensity is done by headache severity scale of IHS. Headache management includes pharmacological and non-pharmacological treatment.
Keywords: Clinical history, International classification of headache disorders, International Headache Society, Primary headache, Secondary headache.
INTRODUCTION
Headache disorders, characterized by recurrent headache, are the most 
common disorders of the nervous system. Headache itself is a painful 
and disabling feature of a small number of primary headache disorders, 
namely, migraine, tension-type headache (TTH), cluster headache 
(CH), and chronic daily headache (CDH) syndromes cause substantial 
levels of disability [1]. Headache is an extremely common and universal 
symptom with a complex and heterogeneous set of causes. Nearly 
half of the world’s adult population has an active headache disorder. 
The World Health Organization reports that almost half of all adults 
worldwide will experience a headache in any given year and it has a 
major impact on public health [2]. In 1962, the Ad Hoc Committee on 
Classification of Headache, on the basis of general consensus, delineated 
15 categories of headaches [3]. In the second edition of the International 
Classification of Headache Disorders (ICHD-2), headache is divided into 
primary disorders, without an underlying cause and the secondary 
disorders, attributable to a specific etiology [4]. The generally accepted 
diagnostic criteria for primary headaches are those published by the 
International Headache Society (IHS), such as the ICHDs [5]. Headache 
affects people of all ages, races, and socioeconomic status and is more 
common in women.
Primary CDH is subdivided into transformed migraine, chronic TTH, 
hemicrania continua (HC), and new daily persistent headache (NDPH), 
they constitute nearly 98% of all headaches [6]. However, secondary 
headaches are important to recognize as these are serious and may 
be life threatening. Headaches are often treatable with medications 
and/or lifestyle changes. Headaches somewhat more broadly cover 
both painful and non-painful discomforts of the entire head [7]. 
They are one of the most common medical complaints; most people 
experience them at some point in their life. Headaches occur typically 
with regular circadian timings and circannual (mainly in the autumn 
and spring) [8]. In general population, headache is very common that 
it is difficult to identify individuals who have never had a headache. 
Migraine is the second most common cause of headache disorder [9]. 
For many individuals, the consumption of an analgesic or taking a 
short rest period is a sufficient remedy. However, there are also many 
other individuals who are severely in capacitated by headache and 
for whom no known effective treatment exists [3]. In the past, most 
headache classifications have been based on hypothetical pathogenetic 
mechanisms example, “vascular headache” and “muscle contraction 
headache.” Due to poor understanding of the pathophysiology of most 
headaches, the current headache classification developed in the year 
1988 by the IHS according to the expertise of groups of field specialists. 
Following the example of Diagnostic and Statistical Manual of Mental 
Disorders (which are similar to headaches as regards the lack, in 
both disorders, of laboratory or instrumental markers), operational 
diagnostic criteria for each headache type and subtype were established. 
Such an approach inevitably implies the need for subsequent revisions 
based on field testing and clinical experience to improve the adherence 
of the classification to clinical reality. Several studies have shown that 
the IHS classification is a suitable tool for describing headache in the 
general population.
CLASSIFICATION OF HEADACHE




The short-lasting primary headache syndromes may be such as 
conjunctival injection, lacrimation, nasal congestion, and conveniently 
divided into those exhibiting marked autonomic rhinorrhea, ptosis, 





3. Trigeminal autonomic cephalalgias
4. Other primary headache disorders.
Migraine
Migraine is a neurovascular disease with a broad spectrum of symptoms 
and is a common disabling primary headache disorder. The migraine 
headache is ubiquitous, disabling, prevailing, and essentially treatable, but 
still under-estimated and under-treated [11]. Migraine headache is usually 
frontotemporal. Migraine, high prevalence and high socioeconomic, was 
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documented in the epidemiological studies. One in 10 people will surely 
have migraine [12]. Migraine is a common chronic headache disorder 
characterized by recurrent attacks lasting 4 h–72 h. It has been termed 
the seventh disabler due to its considerable impact on the quality of life 
of patient. It is the most frequent cause of headache in the children and 
adolescents. Unilateral pain is usually seen in late adolescence or in the 
early adult life [13]. The IHS criteria are very helpful in the diagnosis of 
migraine [12]. There are two major subtypes of migraine.
•	 A clinical syndrome which is characterized by headache with some 
specific features and also associated symptoms is migraine without 
aura
•	 Migraine with aura is characterized by transient focal neurological 
symptoms and they usually precede or sometimes accompany 
the headache. Migraine aura symptoms include temporary 
visual or sensory disturbances that usually strike before other 
migraine symptoms, they are like head pain, nausea, and sensitivity 
to light and sound which usually seen within an hour before head 
pain starts and last less than an hour after the attack [13].
Classification of migraine
The classification of migraine has been impeded by the lack of 
pathognomonic markers for migraine, cooccurrence of migraine, and 
its subtypes as well as TTH within the same individual, the lack of 
validity of inclusion criteria, and thresholds for distinguishing disorder 
from non-disorder and the boundaries between migraine and other 
headache subtypes and classification of migraine is given in Table 1.
Migraine without aura
It is the recurrent headache disorder manifesting in attacks lasting 4 
h–72 h. Migraine headache as compared with adults, it is more often 
bilateral in children and adolescents (aged <18 years) and the unilateral 
pain usually seen in the early adult life [11]. In some cases, people with 
migraine have some specific warning symptoms or an aura before the 
onset of their headache. Some of those warning signs includes as from 
flashing lights/blind spot in one eye to numbness/weakness involving 
one side of the body. By some routine physical activity, the headache 
may be aggravated sometimes, occurs at unilateral location and it is in 
pulsating quality with mild, moderate, or severe intensity and associated 
with nausea or vomiting, phonophobia, and photophobia. Photophobia 
and phonophobia may be inferred from their behavior in young children. 
Migraine without aura often has a menstrual relationship [11,13]. 
Diagnostic criteria for migraine without aura are shown in Table 2.
Migraine with aura
It occurs as recurrent attacks which lasts within few minutes as unilateral 
fully reversible sensory, visual, or some other symptoms are seen which 
will usually develop slowly and some of the main migraine aura symptoms 
include temporary visual or sensory disturbances that usually strike 
before other migraine symptoms, they are such as head pain, nausea, 
and sensitivity to light and sound [14]. Aura is described as a complex of 
neurological symptoms that occur before the headache starts. Symptoms 
of aura can be visual or sensory and may include blind spots, zigzag 
lines, shimmering stars, changes or loss in vision, and flashes of light [2]. 
Migraine aura consists of a usually transient clinical disturbance and that 
may attributed to brain dysfunction. Five aura symptoms may last longer 
than 7 days in migraine sufferers and the second edition of the classification 
defines migraine [15]. Migraine has a variety of subtypes, some of which 
are associated with hemiplegia. Aura is highly variable and is thought to 
be generated from many areas of the cortex or brain stem. Aura symptoms 
include as visual, sensory, motor, brainstem, retinal, speech, and language.
Visual disturbances
The visual aura symptoms of migraine are subjective phenomenon and 
it is seen in 90% with migraine with aura patients and it is inaccessible 
to normal people that which a migraine person will experiences [13,16]. 
Most migraineurs have increased sensitivity to light and other visual 
stimuli during migraine attacks and can see visuals like Fig. 1 [17].
Positive symptoms, such as light flashes, spots, or zig-zag lines
•	 Negative symptoms, which are present when there is any loss of 
vision or blind spots as part of the aura phase
•	 Distorted vision symptoms
•	 Vertigo and dizziness
•	 Light sensitivity and photophobia [16].
Sensory symptoms include
It most commonly begins with some unilateral tingling or the 
“Paresthesia” in the distal portion of one of the extremities, mainly 
the upper extremities then after it will slowly spread to the hands 
and forearms also [18]. Tingling and paresthesia are the first sensory 
symptom [19].
Motor symptoms include
The unilateral tearing, bilateral tearing, neck pain before headache, and 
neck pain during headache.
Types: Along with above-mentioned symptoms, migraine with aura is 
further classified into fallowing types, they are as follows:
Table 1: Classification of migraine from the international 
classification of headache disorders, 3rd edition (beta version)
1.1 Migraine without aura
1.2 Migraine with aura
1.2.1 Migraine with typical aura
1.2.1.1 Typical aura with headache
1.2.1.2 Typical aura without headache
1.2.2 Migraine with brainstem aura
1.2.3 Hemiplegic migraine
1.2.3.1 Familial hemiplegic migraine
1.2.3.1.1 Familial hemiplegic migraine type 1
1.2.3.1.2 Familial hemiplegic migraine type 2
1.2.3.1.3 Familial hemiplegic migraine type 3
1.2.3.1.4 Familial hemiplegic migraine, other loci
1.2.3.2 Sporadic hemiplegic migraine
1.2.4 Retinal migraine
1.3 Chronic migraine
1.4 Complications of migraine
1.4.1 Status migrainosus
1.4.2 Persistent aura without infarction
1.4.3 Migrainous infarction
1.4.4 Migraine aura-triggered seizure
1.5 Probable migraine
1.5.1 Probable migraine without aura
1.5.2 Probable migraine with aura
1.6 Episodic syndromes that may be associated with migraine
1.6.1 Recurrent gastrointestinal disturbance
1.6.1.1 Cyclical vomiting syndrome
1.6.1.2 Abdominal migraine
1.6.2 Benign paroxysmal vertigo
1.6.3 Benign paroxysmal torticollis [13]
Table 2: Diagnostic criteria for migraine without aura, from 
headache classification committee of the International 
Headache Society, 2018
A. At least five attacks fulfilling criteria B–D
B.  Headache attacks lasting 4 h–72 h (when untreated or 
unsuccessfully treated)
C. Headache has at least two of the following four characteristics:
 1. Unilateral location
 2. Pulsating quality
 3. Moderate or severe pain intensity
 4. Aggravation by or causing avoidance of routine
 5. Physical activity (e.g., walking or climbing stairs)
D. During headache at least one of the following:
  Nausea and/or vomiting
  Photophobia and phonophobia
E. Not better accounted for by another ICHD-3 diagnosis [13]
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a. Migraine with typical aura
b. Migraine with brainstem aura
c. Hemiplegic migraine
d. Retinal migraine [13,16].
Table 3 shows diagnostic criteria for migraine with aura, from the 
headache classification committee of the IHS.
Chronic migraine
The IHS defines chronic migraine as more than 15 headache days per 
months over a period of 3 months and in the absence of medication 
over use, more than 8 are migrainous. Headache that occurs for 15 
days or more days/months for more than 3 months, at least 8 days/
months, has migraine headache features. It is a chronic daily/near-daily 
headache with migraine [20].
Complications of Migraine
a. Status migrainosus
b. Persistent aura without infarction
c. Migrainous infarction
d. Migraine aura-triggered seizure.
Probable migraine
Migraine-like attacks missing one of the features are required to fulfill 
all criteria for a type or subtype of the migraine which is coded above 
and not fulfilling criteria for another headache disorder. These are 
classified into:
a. Probable migraine without aura
b. Probable migraine with aura.
Episodic migraine
a. Recurrent gastrointestinal disturbance
b. Cyclic vomiting syndrome
c. Abdominal migraine
d. Benign paroxysmal vertigo
e. Benign paroxysmal torticollis.
TTH
TTH is a neurological disorder and most common, prevalent types of 
headache and important type of primary headaches. It represents a 
considerable health and socioeconomic problem. It is a disabling and 
associated with some psychiatric comorbidities [21-23]. Since many 
years, this headache has been called by various names such as tension 
headache, muscle contraction headache, psychomyogenic headache, 
psychogenic headache, ordinary headache, idiopathic headache, 
essential headache, and stress headache [24]. It is characterized 
by a predisposition to attacks of mild-to-moderate headache with 
some associated symptoms [22]. Increased tenderness of pericranial 
myofascial tissues to manual palpation is the most prominent abnormal 
finding in patients with TTH. Painful impulses from these tissues 
may be related to the head and perceived as headache and myofascial 
mechanisms may, therefore, play a major role in the pathophysiology 
of TTH [21]. The diagnostic criteria for TTH are different and they are 
negation of those for migraine, for example, not bilateral, non-pulsating, 
and not aggravated by physical activity and so sometimes people 
experience both types, migraine and TTH [24]. The diagnosis ranges 
from non-life-threatening processes such as migraine to life-threatening 
conditions such as subarachnoid hemorrhage. Missing a life-threatening 
condition may result in adverse patient outcomes and may also pose 
the potential for medico legal liability. For these reasons, the American 
college of emergency physicians choose headache as a clinical policy 
topic [25]. The original headache clinical policy was published in June 
1996. The pathogenetic mechanism underlying TTH is still unclear. The 
exact mechanism of TTH is unknown [13,25]. Diagnostic criteria for TTH 
are given in Table 4 and its classification is shown in Table 5.
In IHS classification (ICHD II), TTH have been divided into two forms, 
episodic (ETTH) and chronic (CTTH) and divided into three types based 
on the frequency of attack, they are shown in Table 6:
Trigeminal autonomic cephalalgias
The trigeminal autonomic cephalalgias (TACs) are a group of primary 
headache syndromes which are characterized by strictly unilateral 
head pain and they are rare, short-lasting, disabling primary headaches 
Table 3: Diagnostic criteria for migraine with aura, from 
headache classification committee of the International 
Headache Society, 2018
A. At least two attacks fulfilling criteria B and C








C. At least three of the following six characteristics
 1. At least one aura symptom spreads gradually over 5 min
 2. Two or more aura symptoms occur in succession
 3. Each individual aura symptom lasts 5 min–60 min
 4. At least one aura symptom is unilateral
 5. At least one aura symptom is positive
 6.  The aura is accompanied, or followed within 60 min, by headache
E. Not better accounted for by another ICHD-3 diagnosis [13]
Table 4: Diagnostic criteria for tension-type headache, from 
headache classification committee of the International 
Headache Society, 2018
A. At least 10 episodes fulfilling the criteria B-D
B. Headache lasting from 30 min to 7 days
C. Headache has at least two of the following characteristics
 1. Bilateral location
 2. Pressing/tightening (non-pulsating) quality
 3. Mild or moderate intensity
 4.  Not aggravated by routine physical activity such as walking or 
climbing stairs
D. Both of the following
 1. No nausea or vomiting (anorexia may occur)
 2. No more than 1 episode of photophobia or phonophobia
E. Not attributable to another disorder [13]
Table 5: Classification of tension-type headache from the 
international classification of headache disorders, 3rd edition 
(beta version)
2.1. Infrequent episodic tension-type headache 
2.1.1  Infrequent episodic tension-type headache associated with 
pericranial tenderness
2.1.2  Infrequent episodic tension-type headache not associated 
with pericranial tenderness
2.2. Frequent episodic tension-type headache 
2.2.1  Frequent episodic tension-type headache associated with 
pericranial tenderness
2.2.2 Frequent episodic tension-type headache not associated with 
pericranial tenderness
2.3. Chronic tension-type headache 
2.3.1 Chronic tension-type headache associated with pericranial 
tenderness 
2.3.2  Chronic tension-type headache not associated with 
pericranial tenderness
2.4. Probable tension-type headache 
2.4.1 Probable infrequent episodic tension-type headache
2.4.2 Probable frequent episodic tension-type headache
2.4.3 Probable chronic tension-type headache [13]
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and associated with ipsilateral cranial autonomic features such as 
conjunctival injection and tearing (SUNCT) [27,28]. The TACs primary 
headache disorders include CH, paroxysmal hemicrania (PH), and 
short-lasting unilateral neuralgiform headache attacks.
TACs are classified as five types depending on the severity, frequency, 
and location of headache and they are given in Table 7.
CH
It is a form of primary neurovascular headache with some features 
like severe unilateral, though the headache may alternate on sides, 
commonly retro-orbital lasting for about 15 min–180 min, pain 
accompanied by restlessness and cranial autonomic symptoms like 
conjunctival injection [13]. CH is a rare disorder mainly effects men, 
with a prevalence of <1%. A cluster bout or period refers to the duration 
of recurrent cluster attacks. CH is included with the shorter-lasting 
headaches to attempt a nosological analysis of these syndromes [10]. 
Some autonomic symptoms, during the headache attacks accompanying 
CH, include nasal congestion, unilateral ptosis, lacrimation, miosis, 
ear fullness, and conjunctival injection. Based on this symptoms, CH 
is classified as a prototype autonomic cephalalgia by the diagnostic 
criteria of the ICHD [10,13]. CH attacks vary individually and usually 
last between 15 min and 180 min, and during cluster periods, they occur 
up to 8 times/days with regular circannual and circadian timing [29]. 
Some older terms of CH are as ciliary neuralgia, migrainous neuralgia, 
and Horton’s headache histaminic cephalalgia. Based on frequency of 
episodes and duration, CH is divided into
1. Episodic CH, manifests bout periods lasting from 7 days to 1 year, 
accounts for 80–90% of CH cases, during which patients may 
experience daily attacks at a high frequency and asymptomatic out-
of-bout remission periods that last for months to years at a time and
2. When patients experience a full year without remission or if the 
duration of remission is <30 days then, it is diagnosed as chronic 
CH (10–20% of cases) [13].
PH
In this type of headache, symptoms such as severe attacks, strictly 
unilateral pain which is supraorbital, orbital, temporal, or in any other 
combination of such type which lasts in about 2 min–30 min and occurs 
several/many times a day are seen. Pain attacks are associated with the 
ipsilateral conjunctival injection, lacrimation, rhinorrhea, sweating of 
facial and forehead, eyelid edema, and ptosis [13,30]; in 1974, Sjaastad 
and Dale first described the chronic PH is a primary headache disorder 
and included in the IHS classification of 1988 [30].
PH is classified into 
1. Episodic CH
2. Chronic CH.
Short-lasting unilateral neuralgiform headaches attacks
This type of headache is seen with, severe-to-moderate attacks, which 
may be associated usually with prominent lacrimation and redness of 
ipsilateral eye and strictly unilateral head pain which is lasting from 
seconds to minutes which is seen at least once a day.
Without a refractory period, these subtypes usually be triggered [13].
Short-lasting unilateral neuralgiform headache attacks are recognized
a. Short-lasting unilateral neuralgiform headache attacks with 
conjunctival injection and tearing (SUNCT) 
1. Episodic SUNCT
2. Chronic SUNCT.
b. Short-lasting unilateral neuralgiform headache attacks with cranial 
autonomic symptoms (SUNA)
1. Episodic SUNA
2. Chronic SUNA [13].
HC
HC is an indomethacin responsive headache disorder characterized 
by a continuous, strictly unilateral headache associated with nasal 
congestion, ipsilateral conjunctival injection, sweating of facial/
forehead, eyelid edema, miosis, waning, and waxing which did not 
disappears completely [13,31]. It takes precedence over the diagnosis 
of other types of CDH. HC is included in Group 4 of ICHD ICHD-II [32].
a. HC, remitting subtype: HC characterized by pain that is not 
continuous but is interrupted by remission periods of at least 24 h 
duration
b. HC, unremitting subtype: HC characterized by continuous pain for 
at least 1 year, without remission periods of at least 24 h [13].
Probable TAC
Headache attacks are the type or subtype of TACs, in which one of 
the features required to fulfill all the criteria for any of the type and 
subtypes coded above are missing and do not fulfill all criteria for 
another headache disorder.
a. Probable CH 
b. Probable PH
c. Probable short-lasting unilateral neuralgiform headache attacks
d. Probable HC [13].
Other primary headache disorders
Primary cough headache
It is defined as headache precipitated by coughing, but not by prolonged 
physical exercise, in the absence of any intracranial disorder. Headache 
immediately reaches to its peak and subsides over several seconds to 
few minutes. Primary cough headache is usually bilateral and posterior 
Table 7: Classification of trigeminal autonomic cephalalgias 
from the international classification of headache disorders, 3rd 
edition (beta version)
3.1 Cluster headache
3.1.1 Episodic cluster headache
3.1.2 Chronic cluster headache
3.2 Paroxysmal hemicrania
3.2.1 Episodic paroxysmal hemicranias
3.2.2 Chronic paroxysmal hemicranias
3.3 Short-lasting unilateral neuralgiform headache attacks
3.3.1  Short-lasting unilateral neuralgiform headache attacks with 
conjunctival injection and tearing (SUNCT)
3.3.1.1 Episodic SUNCT
3.3.1.2 Chronic SUNCT
3.3.2  Short-lasting unilateral neuralgiform headache attacks with 




3.4.1 Hemicrania continua, remitting subtype
3.4.2 Hemicrania continua, unremitting subtype
3.5 Probable trigeminal autonomic cephalalgia
3.5.1 Probable cluster headache
3.5.2 Probable paroxysmal hemicranias
3.5.3  Probable short-lasting unilateral neuralgiform headache 
attacks
3.5.4 Probable hemicrania continua [13]




Frequent ETTH Chronic TTH
Frequency <12 days/year More than 12 days 
and <180 days/year
At least 10 episodes 
occurring more than 
1 day and <15 days/
month for at least 3 
months
More than 180 
days/year
more than 15 
days/months 
for at least 3 
months
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and patients who are older than 40 years of age are predominantly 
affected. Two-thirds of patients with primary cough headache have 
been reported some associated symptom such as vertigo, nausea, and 
abnormality in sleeping.
Based on diagnostic criteria, it is classified as follows:
a. Probable primary cough headache
The diagnostic criteria are shown in Table 8.
Primary exercise headache
Headache which is precipitated by any form of exercise in the absence 
of any intracranial disorder is defined as primary exercise headache. It 
occurs particularly in hot weather or at high altitude. Diagnostic criteria 
are given in Table 9, and based on diagnostic criteria, it is classified as 
follows:
a. Probable primary exercise headache.
Primary headache associated with sexual activity
Headache which is precipitated by sexual activity is defined as primary 
headache associated with sexual activity, usually starting as a dull 
bilateral ache as sexual excitement increases and suddenly becoming 
intense at orgasm, in the absence of any intracranial disorder.
Based on diagnostic criteria as shown in Table 10, it is classified as 
follows:
a. Probable primary headache associated with sexual activity.
Primary thunderclap headaches
High-intensity headache of sudden onset, mimicking ruptured cerebral 
aneurysm, in the absence of any intracranial pathology and is like clap 
of thunder. Thunderclap headache is frequently associated with serious 
vascular intracranial vascular disorders and its diagnostic criteria are 
shown in Table 11.
Cold-stimulus headache
Headache which is seen when any cold stimulus applied externally 
to the head or any cold product was ingested or inhaled. Based on 
diagnostic criteria as shown in Table 12, it is classified as follows:
a. Headache caused/associated or seen by an external application of a 
cold stimulus
b. Headache caused due to ingestion or inhalation of a cold stimulus
c. Probable cold-stimulus headache.
I. Headache probably seen due to external application of a cold 
stimulus
II. Headache probably seen due to ingestion or inhalation of a cold 
stimulus.
External pressure headaches
It is defined as headache which is resulting from a sustained compression 
or traction on pericranial soft tissues. It is classified as follows:
a. External compression headache
b. External traction headache
c. Probable external pressure headache.
I. Probable external compression headache
II. Probable external traction headache.
Primary stabbing headache
Transient and localized stabs of pain in the head that occur 
spontaneously in the absence of organic disease of underlying 
structures or of the cranial nerves are seen in this type of headache. It 
involves extra-trigeminal regions in 70% of cases.
Based on diagnostic criteria given in Table 13, primary stabbing 
headache is classified as follows:
a. Probable primary stabbing headache.
Nummular headache
Pain of highly variable duration, but often chronic, in a small 
circumscribed area of the scalp and in the absence of any underlying 
structural lesion is seen in this type of headache.
Based on diagnostic criteria shown in Table 14, nummular headache is 
classified as follows:
a. Probable nummular headache.
Hypnic headache
Frequently recurring headache attacks that are developing only 
during sleep and causing wakening and lasting for up to 4 h, without 
characteristic associated symptoms and not attributed to other 
Table 8: Diagnostic criteria of primary cough headache
A. At least two headache episodes fulfilling criteria B–D
B.  Brought on by and occurring only in association with coughing, 
straining, and/or other Valsalva maneuver
C. Sudden onset
D. Lasting between 1 s and 2 h
E. Not better accounted for by another ICHD-3 diagnosis [13]
Table 9: Diagnostic criteria of primary exercise headache
A. At least two headache episodes fulfilling criteria B and C 
B.  Brought on by and occurring only during or after strenuous 
physical exercise
C. Lasting <48 h
D. Not better accounted for by another ICHD-3 diagnosis [13]
Table 10: Diagnostic criteria of primary headache associated 
with sexual activity
A.  At least two episodes of pain in the head and/or neck fulfilling 
criteria B–D
B. Brought on by and occurring only during sexual activity
C. Either or both of the following: 
1. Increasing in intensity with increasing sexual excitement
2. Abrupt explosive intensity just before or with orgasm
D.  Lasting from 1 min to 24 h with severe intensity and/or up to 72 h 
with mild intensity
E. Not better accounted for by another ICHD-3 diagnosis [13]
Table 11: Diagnostic criteria of primary thunderclap headache
A. Severe head pain fulfilling criteria B and C
B. Abrupt onset, reaching maximum intensity in <1 min
C. Lasting for 5 min
D. Not better accounted for by another ICHD-3 diagnosis [13]
Table 12: Diagnostic criteria of cold-stimulus headache
A. At least two acute headache episodes fulfilling criteria B and C
B.  Brought on by and occurring only during application of an 
external cold stimulus to the head
C. Resolving within 30 min after removal of the cold stimulus
D. Not better accounted for by another ICHD-3 diagnosis [13]
Table 13: Diagnostic criteria of primary stabbing headache
A.  Head pain occurring spontaneously as a single stab or series of 
stabs and fulfilling criteria B and C
B. Each stab lasts for up to a few seconds
C. Stabs recur with irregular frequency, from one to many per day
D. No cranial autonomic symptoms
E. Not better accounted for by another ICHD-3 diagnosis [13]
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pathology. Hypnic headache is a rare headache syndrome first described 
by Raskin in 1988 and has also been called clockwise headache or alarm 
clock headache and is regarded as an idiopathic headache disorder [33].
Diagnostic criteria is given in Table 15, and based on diagnostic criteria, 
it is classified as follows:
a. Probable hypnic headache.
New Daily Persistent Headache (NDPH)
Persistent headache which occurs on daily basis with past history of 
frequent headaches. Diagnostic criteria are given in Table 16, and based 
on diagnostic criteria, it is classified as follows:
a. Probable NDPH.
Differential diagnosis of headache
Most of the types of headache are diagnosed by the clinical history alone 
also. Sometimes neuroimaging and lumbar puncture may be necessary 
and Table 17 shows differential diagnosis of headache.
The secondary headaches
When the headache occurs in a patient due to a secondary or with any 
underlying cause, it is said to be secondary headache. A secondary 
headache is a symptom of a disease that can activate the pain-sensitive 
nerves of the head. The secondary headaches are “attributed to” another 
disorder since “the causal link between the underlying disorder and the 
headache is in most cases well-established.” According to the ICHD-II, 
one of the main consequences of the rigorous separation is that the 
classification and diagnostic criteria differ in that they are etiological 
for secondary headaches and symptom based for primary headaches. 
The following constellations are possible:
•	 A new headache that occurs together along with another disorder is 
known to cause the headache. This type of headache independent of 
the clinical phenotype is said to be as a secondary headache
•	 During the time of occurrence of another disorder if a pre-existing 
headache is worsened, then that is known to cause headache and it 
has to be decided by seeing whether the patient is given the diagnosis 
of the pre-existing headache or the diagnosis of both the primary 
headache and the secondary headache. Factors in favor of a secondary 
headache are as follows:
i. A close temporal relationship between the worsening of 
headache and the manifestation of the probable causative 
disorder
ii. A significant worsening
iii. Evidence which shows that the disorder can aggravate the 
primary headache and
iv. Improvement of the headache after relief of the causative 
disorder.
In other words, a secondary headache can either be diagnosed if the 
additional disorder can cause headache or if certain associations are 
present between the additional disorder and the headache. Otherwise, 
the primary disorder is diagnosed [35]. Any number of conditions 
varying greatly in severity may cause secondary headaches. Possible 
causes of secondary headaches include:
•	 Acute sinusitis (sinus infection)
•	 Arterial tears (carotid or vertebral dissections)
•	 Venous thrombosis within the brain
•	 Brain aneurysm (a bulge in an artery in your brain)
•	 Brain arteriovenous malformation: An abnormal formation of brain 
blood vessels
•	 Brain tumor and stroke
•	 Chiari malformation (structural problem at the base of your skull)
•	 Dehydration
•	 Dental problems and ear infections
•	 Encephalitis
•	 Giant cell arteritis (inflammation of the lining of the arteries)
•	 Glaucoma
•	 Hangovers
•	 High blood pressure (hypertension)
•	 Influenza and other febrile illnesses
•	 Intracranial hematoma
•	 Medications to treat other disorders
•	 Meningitis
•	 Monosodium glutamate
•	 Overuse of pain medication
•	 Panic attacks and panic disorder
•	 Post-concussion syndrome
•	 Pressure from tight headgear, such as a helmet or goggles
•	 Trigeminal neuralgia (as well as other neuralgias, all involving 
irritation of certain nerves connecting the face and brain).
Diagnostic criteria of secondary headache are given in Table 18 from 
the headache classification committee of the IHS.
Secondary headaches are classified as following types based on ICHD 
diagnostic criteria they are as follows:
a. Headache attributed to trauma or injury to the head and/or neck
b. Headache attributed to cranial and/or cervical vascular disorder
c. Headache attributed to non-vascular intracranial disorder
d. Headache attributed to a substance or its withdrawal
e. Headache attributed to infection
f. Headache attributed to disorder of homoeostasis
g. Headache or facial pain attributed to disorder of the cranium, neck, 
eyes, ears, nose, sinuses, teeth, mouth, or other facial or cranial 
structure
h. Headache attributed to psychiatric disorder [13].
Headache attributed to trauma or injury to the head and/or neck
Headache of <3 months duration caused by traumatic injury to the 
head.
Classification
•	 Acute headache attributed to traumatic injury to the head
•	 Persistent headache attributed to traumatic injury to the head
•	 Acute headache attributed to whiplash
•	 Persistent headache attributed to whiplash
•	 Acute headache attributed to craniotomy
•	 Persistent headache attributed to craniotomy.
Table 15: Diagnostic criteria of hypnic headache
A. Recurrent headache attacks fulfilling criteria B–E
B. Developing only during sleep and causing wakening
C. Occurring on >10 days/month for >3 months
D. Lasting from 15 min up to 4 h after waking
E. No cranial autonomic symptoms or restlessness
F. Not better accounted for by another ICHD-3 diagnosis [13]
Table 16: Diagnostic criteria of new daily persistent headache
A. Persistent headache fulfilling criteria B and C
B. Distinct and clearly remembered onset, with pain becoming 
continuous and unremitting within 24 h
C. Present for >3 months
D. Not better accounted for by another ICHD-3 diagnosis [13]
Table 14: Diagnostic criteria of nummular headache
A. Continuous or intermittent head pain fulfilling criterion B 
B.  Felt exclusively in an area of the scalp, with all of the following 
four characteristics: 
1. Sharply contoured
2. fixed in size and shape
3. Round or elliptical
4. 1–6 cm in diameter
C. Not better accounted for by another ICHD-3 diagnosis [13]
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Headache attributed to cranial and/or cervical vascular disorder
An underlying cranial and/or cervical vascular condition is the onset, 
usually sudden, of a new headache, so far unknown to the patient. 
Whenever this occurs, vascular conditions should urgently be looked for.
Classification
•	 Headache attributed to cerebral ischemic event
•	 Headache attributed to non-traumatic intracranial hemorrhage
•	 Headache attributed to unruptured vascular malformation
•	 Headache attributed to arteritis
•	 Headache attributed to cervical carotid or vertebral artery disorder
•	 Headache attributed to cranial venous disorder
•	 Headache attributed to other acute intracranial arterial disorder
•	 Headache and/or migraine-like aura attributed to chronic 
intracranial vasculopathy
•	 Headache attributed to pituitary apoplexy.
Headache attributed to non-vascular intracranial disorder
After successful treatment if headache persisting for more than 1 month 
or spontaneous resolution of the intracranial disorder usually has other 
mechanisms. Usually headache persists for more than 3months after 
treatment or remission of intracranial disorders.
Classification
•	 Headache attributed to increased cerebrospinal fluid (CSF) pressure
•	 Headache attributed to low CSF pressure
•	 Headache attributed to non-infectious inflammatory intracranial 
disease
•	 Headache attributed to intracranial neoplasia
•	 Headache attributed to intrathecal injection
•	 Headache attributed to epileptic seizure
•	 Headache attributed to Chiari Malformation Type I
•	 Headache attributed to other non-vascular intracranial disorder.
Headache attributed to a substance or its withdrawal
Associations between headache and substances are often anecdotal, 
many based on reports of adverse drug reactions. Headache can 
occur by chance and may be a symptom of a systemic disease and 
drugs given to treat such a condition will be associated with the 
headache.










Pain location Bilateral Unilateral or bilateral Unilateral (around the eye, above 
the eye, and along the side of the 
head/face)
Bilateral Unilateral
Pain quality Pressing/tightening 
(non-pulsating)
Pulsating (throbbing or banging 
in young people aged 12 years–17 
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Not aggravated by 
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daily living
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Some disorders may predispose to drug-related headache alone, 
neither the drug nor the condition would produce headache.
Classification
•	 Headache attributed to use of or exposure to a substance
•	 Medication overuse headache
•	 Headache attributed to substance withdrawal.
Headache attributed to infection
Headache is a common accompaniment for some of the systemic viral 
infections such as influenza and also with sepsis and more rarely, it may 
accompany other systemic infections. In the intracranial infections, 
headache is most frequently encountered symptom and usually the 
first.
Occurrence of a new type of headache that is diffuse and associated 
with focal neurological signs and/or altered mental state and a general 
feeling of illness and sometimes fever should be an attention toward an 
intracranial infection even in the absence of neck stiffness.
Classification
•	 Headache attributed to intracranial infection
•	 Headache attributed to systemic infection.
Headache attributed to disorder of homoeostasis
The headache disorders within this category were previously referred 
to as headache associated with metabolic or systemic disease.
However, headache attributed to disorder of homoeostasis was felt to 
more fully encompass disorders of homeostatic mechanisms affecting 
a variety of organ systems, including altered arterial blood gases, 
systemic arterial pressure, volume disturbances that occur as a result 
of dialysis, and disorders of endocrine function.
Classification
•	 Headache attributed to hypoxia and/or hypercapnia
•	 Dialysis headache
•	 Headache attributed to arterial hypertension
•	 Headache attributed to hypothyroidism
•	 Headache attributed to fasting
•	 Cardiac cephalalgia
•	 Headache attributed to other disorder of homoeostasis.
Headache or facial pain attributed to disorder of the cranium, 
neck, eyes, ears, nose, sinuses, teeth, mouth, or other facial/cranial 
structure
Disorders of the cervical spine and of other structures of the neck and 
head have been regarded as common causes of headache, since many 
headaches seem to originate from the cervical, nuchal, or occipital 
regions or are localized there. Degenerative changes in the cervical 
spine can be found in virtually all people over 40 years of age.
Spondylosis or osteochondrosis is, therefore, not conclusively the 
explanation of associated headache.
Classification
•	 Headache attributed to disorder of cranial bone
•	 Headache attributed to disorder of the neck
•	 Headache attributed to disorder of the eyes
•	 Headache attributed to disorder of the ears
•	 Headache attributed to disorder of the nose or paranasal sinuses
•	 Headache attributed to disorder of the teeth
•	 Headache attributed to temporomandibular disorder
•	 Head or facial pain attributed to inflammation of the stylohyoid 
ligament
•	 Headache or facial pain attributed to other disorder of cranium, neck, 
eyes, ears, nose, sinuses, teeth, mouth, or other facial or cervical 
structure.
Headache attributed to psychiatric disorder
Headache disorders that occur coincidentally some psychiatric 
disorders such as depressive disorders, acute stress disorder, anxiety 
disorders, trauma, and stress-related disorders (reactive attachment 
disorder, post-traumatic stress disorder, and adjustment disorders).
In such conditions, when there is no evidence of a causal relationship, 
headache diagnosis and also a separate psychiatric diagnosis both 
should be made.
Classification
1. Headache attributed to somatization disorder
2. Headache attributed to psychotic disorder [13].
Clinical features of headache
Headache symptoms depend on the type of headache. The frequency 
of headaches and the intensity of the symptoms may vary as well. 
Symptoms that may suggest a more serious headache include any of 
the following:
•	 Headaches that start early in the morning
•	 Pain that is worsened by strain, such as a cough or a sneeze
•	 Vomiting without nausea
•	 Sudden onset of pain and the “worst headache” ever
•	 Headache that is becoming more severe or continuous
•	 Personality changes
•	 Changes in vision
•	 Weakness in the arms or legs
•	 Seizures and
Some common symptoms are such as dull, aching head pain, 
sensation of tightness or pressure across your forehead or on the 
sides and back of your head, tenderness on your scalp, neck, and 
shoulder muscles, nausea and vomiting, giddiness, phonophobia, 
and photophobia (pain in the eyes when looking into bright lights), 
tightness sensation in the head, hyperactivity or hypo activity, food 
cravings, and depression.
Pathophysiology
The brain itself is not sensitive to pain because it lacks pain receptors. 
Some areas of head and neck do have pain receptors and can sense pain. 
These include extracranial arteries, large veins, middle meningeal artery 
the meninges, falx cerebri, parts of the brainstem, venous sinuses, cranial 
and spinal nerves, head–and-neck muscles, eyes, ears, teeth, and lining 
of the mouth. Pial arteries, rather than Pial veins are responsible for pain 
production and process of headache pathophysiology is shown in Fig. 2.
1. Stimulation of primary nociceptors
2. Lesions in pain producing pathways of PNS and CNS.
Table 18: Diagnostic criteria for secondary headaches from 
headache classification committee of the International 
Headache Society, 2018
A. Any headache fulfilling criterion C 
B.  Another disorder scientifically documented to be able to cause 
headache has been diagnosed
C.  Evidence of causation demonstrated by at least two of the 
following: 
1.  Headache has developed in temporal relation to the onset of the 
presumed causative disorder
2. Either or both of the following:
a.   Headache has significantly worsened in parallel with 
worsening of the presumed causative disorder 
b.  Headache has significantly improved in parallel with 
improvement of the presumed causative disorder
3. Headache has characteristics typical for the causative disorder
4. Other evidence exists of causation
D. Not better accounted for by another ICHD-3 diagnosis [13]
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Pain producing pathways
•	 Scalp
•	 Middle meningeal artery
•	 Dural sinuses
•	 Falx cerebri and
•	 Proximal segments of the large pial arteries.
The ventricular ependyma, choroid plexus, pial veins, and much of the 
brain parenchyma are not pain producing.
Diagnosis process of headache
Diagnosis of a headache is made with a careful history, physical 
examination, and by some diagnostic tests and also based on type, 
location of headache, severity, and frequency, type of headache was 
finally diagnosed.
Severity scale
The IHS Grading of Headache Intensity contains 4 steps, including the “zero”, 
“mild”, “moderate” and “severe” diagrammatically shown in Fig. 3 [36].
•	 0: No pain
•	 1: Faint pain – The patient’s mobility and daily activities are not 
impacted and administration of medications is also not necessary
•	 2: Mild pain – Headache pain should be noticed but headache can be 
ignored very easily
•	 3: Moderate pain – Uncomfortable but the pain can be tolerable level 
and is easily noticeable, ignored and the subject can do their daily 
activities also
•	 4: Uncomfortable pain – This level of throbbing head pain that is 
constantly on your mind and the ability to do their daily activities 
will be difficult and the headache is untreated. The pain starts from 
head and slowly moves to the neck also for overtime
•	 5: Distracting pain – Piercing migraine pain that makes it difficult 
to manage the activities of daily living. The subject becomes more 
anxious and psychologically impacted by their pain symptoms and 
also experiences the weakness, blurred vision, and radiating pain in 
the neck-and-head region
•	 6: Distressing pain – Intense migraine pain that controls subjects 
mind set and psychological outlook on their body’s ability to recover. 
In this stage, the subject concerns clinical expertise for a diagnosis 
and treatment regime
•	 7: Unmanageable pain – In this pain score, the pain level dominating 
subjects mindset and outlook on recovery. Subjects reached to a stage 
that the pain level disturbs the subjects the ability to do their daily 
functions and cognitive thinking, so more medical management and 
medical advice are necessary
•	 8: Intense pain – Here, the pain is so intense and both the head 
and neck are experiencing shooting pain which results in tingling, 
numbness, and extreme discomfort is seen, which disturbs the ability 
to do daily activities
•	 9: Severe pain – In these levels, the pain is so intense that the subject 
cannot tolerate the pain and look for more stronger medications and 
medical advice for psychological intervention for the management 
of pain is needed
•	 10: Debilitating pain – This unimaginable level is so intense and the 
subject may go unconscious. During a severe accident, this type of 
pain is likely incurred (e.g., head injury). Emergency treatment is 
needed and the body is unable to recover on its own [36].
Treatment
The ultimate goal of treatment is to stop headaches from occurring and 
the adequate headache management depends on the identification of 
the type of headache and may include the following:
•	 Avoiding known triggers, such as certain foods and beverages, lack of 
sleep and fasting, journey, stress, environmental triggers, and head 
bath
•	 Changing eating habits
•	 Exercise
•	 Resting in a quiet, dark environment
•	 Medications, as recommended by your doctor
•	 Stress management.
Pharmacological treatment
Headache may require some pharmacological treatment and that can 
be acute (abortive) or preventive and some requires both approaches 
in case of frequent severe headaches.
Acute treatment
Acute attacks are treated with ERGOT ALKALOIDS, nonsteroidal anti-
inflammatory drugs (NSAIDs), and triptans and the adjunctive therapy 
includes antiemetic drugs. These drugs control severity of headaches 
at particular level; however, no complete recovery from headache is 
present to treat recurrent attacks [37].
NSAIDs
Some NSAIDs and its doses are shown in Table 19.
Mechanism of action
NSAIDs are a heterogeneous group of compounds. These heterogeneous 
agents have a similar therapeutic action for the treatment of pain, fever, 
and inflammation. The major mechanism of NSAIDs is the inhibition 
of cyclooxygenase, enzyme catalyzing the synthesis of prostaglandins. 
Appropriate and effective treatment for migraine depends on an 
accurate diagnosis.
Ibuprofen is used to relieve pain of headache. Migraine treatment 
includes simple analgesics and NSAIDs [38].
Adverse effects
The most common side effects are vomiting, nausea, constipation, 
diarrhea, reduced appetite, dizziness, and drowsiness. The most serious 
side effects are ulcers, bleeding, kidney failure, and rarely liver failure.
NSAIDs also may cause swelling of the arms and legs due to the 
retention of fluid from their renal effects. 
Triptans
The 5-HT1B/1D receptor agonists, collectively known as triptans, 
are a major advance in the treatment of headache and considered as 
breakthrough in the management of headache [39]. The beneficial 
effects of the triptans in patients with headache are related to their 
multiple mechanisms of action at sites implicated in the pathophysiology 
of headache.
Triptans are thought to work in three main ways:
1. Peripheral inhibition of release of CGRP and substance P from 
trigeminal nociceptive afferents
2. Modulation of second-order neurons centrally in the trigeminocervical 
pathway, including trigeminal nucleus caudalis, periaqueductal gray, 
and the thalamus and finally
3. Vasoconstriction [40,41].
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Triptans are classified as given in Table 20.
Administration of sumatriptan that belongs to the highly effective 
anti-migraine drugs called triptans or 5-HT1B/1D agonists results in 
alleviation or less the severity of the headache [42].
These mechanisms are mediated by 5-HT1B/1D receptors. The high 
affinity of the triptans for 5-HT1B/1D receptors and their favorable 
pharmacologic properties contribute to the beneficial effects of 
these drugs, including rapid onset of action, effective relief of 
headache and associated symptoms, and low incidence of adverse 
effects [43].
Adverse effects
There are only few ADRs with triptans if they are used in proper dose 
and frequency.
There is a risk of coronary spasm in patients with established cardiac 
events and heart disease after taking triptans may occur rarely.
Ergot alkaloids
Ergot alkaloids were the first antimigraine drugs available to treat. 
These are a large group of compounds. Ergot alkaloids are potent 
α-blockers that cause direct smooth muscle contraction. They are 
products of the fungus Claviceps purpurea. Only products of lysergic 
acid are of clinical importance.
Mechanism of action: The ergot alkaloids are nonspecific 5-HT agonists 
and vasoconstrictors. They constrict the arteries and veins by direct 
stimulation of cerebral vascular smooth muscle.
a. Ergotamine and
b. Dihydroergotamine: It is an α1-adrenoceptor antagonist [43].
• Adverse effects: Nausea and vomiting
• Antiemetic: An adjunctive antiemetic is useful drug that is 
effective against vomiting and nausea that accompany headache 
and medication used to treat acute attacks.
• Mechanism of action
 Antiemetic drugs help to block specific neurotransmitters in the 
body and these neurotransmitters trigger impulses such as nausea 
and vomiting so blocking such impulses will shut down them.
Types are as follows:
•	 Dopamine antagonists: Prochlorperazine, metoclopramide, 
chlorpromazine, and domperidone
• Adverse effects: Fatigue, constipation, restlessness, and muscle 
spasms
•	 Antihistamine: Promethazine
• Adverse effects: Sleepiness, dry mouth, and dry nasal passages
•	 Serotonin (5-hydroxytryptamine 3) antagonist: Ondansetron
• Adverse effects: Fatigue, dry mouth, and constipation
Prophylactic/preventive treatment
Preventive treatment might preclude the progression of headache and 
also results in reductions in cost of health care.
Table 20: Triptans classification
Triptans Starting dose Target dose
Sumatriptan 50 mg–100 mg tablet 300 mg
10 mg–20 mg nasal spray 40 mg
25 mg suppository -
6 mg subcutaneous injection 12 mg
Zolmitriptan 2.5 mg–5 mg tablet 10 mg
5 mg nasal spray 10 mg
Eletriptan 40 mg tablet 80 mg
Frovatriptan 2.5 mg tablet 5 mg
Rizatriptan 10 mg tablet 20 mg
Naratriptan 2.5 mg tablet 5 mg
Almotriptan 12.5 mg 25 mg





Tolfenamic acid 200 mg
Table 21: Prophylactic/preventive treatment
Drug class Medication Starting dose Target dose
Beta-blockers Propranolol 10 mg three times daily 40–80 mg 3 times daily
Metoprolol 25 mg twice daily 100 mg twice daily
Atenolol 25 mg once daily 100 mg once daily
Serotonin antagonist Pizotifen 0.5 mg OD, increase by 0.5 
mg every 1–2 weeks
3 mg daily
Antidepressant Tricyclic: Amitriptyline (alternatively nortriptyline) 10 mg 50–75 mg daily
Dosulepin 25 mg 7 5–100 mg
SNRI: Duloxetine (alternatively venlafaxine) 30 mg 60–90 mg
Antiepileptic Topiramate 100 mg 25 mg
Sodium valproate 1000 mg 200 mg
Angiotensin based Candesartan 4 mg OD 12–16 mg OD
Lisinopril 10 mg OD 20–40 mg OD
Calcium channel blocker Flunarizine 5 mg OD 5 mg for a month, then 10 mg
Nutraceutical Riboflavin (Vitamin B2) 400 mg daily -
Magnesium 600 mg DAILY -
CoQ10 100 mg TID -
Alpha-lipoic acid 600 mg DAILY -
Neuromuscular blocker Onabotulinum toxin A (Botox) 200 U -
Fig. 1: Appearance of a common form of typical migraine visual 
aura [18]
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Thus, headache preventive treatment has to be considered in patients 
with:
•	 Two or more attacks per months that significantly interfere with the 
patient’s daily routine activity and produce disability for 4 or more 
days/months
•	 An unsatisfactory or scarce response to acute therapy
•	 Contraindication to acute treatments and adverse effects related to 
them
•	 The use of abortive medications more than twice per week
•	 Uncommon migraine conditions, including hemiplegic migraine, 
migraine with prolonged aura, or migrainous infarction.
Some drug classification and their doses are given in Table 21.
The current NICE guideline suggests first trying either topiramate or a 
beta-blocker. If both are ineffective or contraindicated, then consider 
the acupuncture, gabapentin, botulinum toxin, or riboflavin.
Non-pharmacological treatment
The non-pharmacological therapy is also used in the preventive 
headache treatment. In addition to pharmacological therapy, 
lifestyle changes help in treating headaches [44]. Many non-drug 
techniques are available that can reduce or prevent head pain, such 
as massage, applying cold or heat packs, and avoiding the triggers 
of headache. Hundreds of scientific studies have shown that the 
behavioral therapies for headache yield a substantial headache 
improvement.
Recently concluded four different behavioral treatments, they are 
scientifically sound options for headache prevention.
•	 Relaxation training
•	 Temperature biofeedback (for hand warming) combined with 
relaxation training
•	 Electromyographic biofeedback (for muscle tension reduction)
•	 Cognitive behavior therapy (stress management training) [45]
•	 Complementary treatments and some lifestyle modifications
•	 Sleep and exercise and reducing the stress and increase 
posture [45,46].
CONCLUSION
Headache itself is a painful and disabling feature of a small number 
of primary headache disorders, namely, migraine, TTH, CH, and CDH 
syndromes cause substantial levels of disability and headache occurs 
due to a secondary or with any underlying cause it is said to be secondary 
headaches. Based on diagnostic criteria and intensity of headache, 
classification of headache is done. The ultimate goal of treatment 
is to stop headaches from occurring and the adequate headache 
management depends on the identification of the type of headache 
and may include avoiding known triggers, non-pharmacological, and 
pharmacological treatment. Pharmacological treatment includes 
NSAIDs, triptans, and ergot alkaloids, and preventive treatment is used 
to reduce the frequency, duration, or severity of attacks.
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